How have NXLIW shares performed in 2024?

Nexalin Technology's stock was trading at $0.0088 on January 1st, 2024. Since then, NXLIW shares have increased by 1,800.0% and is now trading at $0.1672. View the best growth stocks for 2024 here .

How do I buy shares of Nexalin Technology?

Shares of NXLIW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:NXLIW

Nexalin Technology (NXLIW) Stock Price, News & Analysis

→ Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad)

Free NXLIW Stock Alerts

$0.17

-0.01 (-5.64%)

(As of 04/25/2024 ET)

Compare

Today's Range: $0.06
▼
$0.18
50-Day Range: $0.01
▼
$0.45
52-Week Range: $0.01
▼
$0.56

Volume: 8,939 shs
Average Volume: 41,987 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Financials SEC Filings Social Media

Get Nexalin Technology alerts:

Ad Colonial Metals

Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share

The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty.

See why the elites are pouring billions into gold.

About Nexalin Technology

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. In addition, it designs and develops Generation 2 and Generation 3, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, Alzheimer's disease, and dementia. The company is based in Houston, Texas.

NXLIW Stock Price History

30 days | 90 days | 365 days | Advanced Chart

NXLIW Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive NXLIW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nexalin Technology and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Medical Devices
Sub-Industry: N/A
Current Symbol: NASDAQ:NXLIW
CUSIP: N/A
CIK: 1527352
Web: www.nexalin.com
Phone: 713 660 1100
Fax: N/A
Employees: 6
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $110,748.00
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

Ms. Marilyn Elson (Age 71)
Controller
Comp: $382.72k
Mr. Mark White (Age 62)
President, CEO, CFO & Director
Comp: $191.29k
Mr. John Patrick Claude
Co-Founder and Director of Engineering & Development
Dr. David Owens M.D. (Age 63)
Chief Medical Officer & Director
Mr. Michael Nketiah (Age 48)
Senior Vice-President of Quality, Regulatory & Clinical Affairs
Comp: $251.6k

Key Competitors

View All Competitors

NXLIW Stock Analysis - Frequently Asked Questions

How have NXLIW shares performed in 2024?: Nexalin Technology's stock was trading at $0.0088 on January 1st, 2024. Since then, NXLIW shares have increased by 1,800.0% and is now trading at $0.1672.
View the best growth stocks for 2024 here.
How do I buy shares of Nexalin Technology?: Shares of NXLIW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NXLIW) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial